Life Science Investing Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer
Life Science Investing Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
